 Field Trip Health NSADAQ: FTRP shares are trading higher after HC Wainwright Co initiated coverage on the stock with a Buy rating and a 20 price target. The firm said it finds the companys valuation compelling ahead of the anticipated Phase 1 top-line data on FT-104, saying it could be a disruptive psilocybin-like treatment. 